A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy

NCT06742190 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Multifocal Motor Neuropathy (MMN)
MMN

Interventions

BIOLOGICAL: Empasiprubart
BIOLOGICAL: IVIG (Intravenous Immunoglobulin)
OTHER: Empasiprubart-placebo
OTHER: IVIg-placebo

Sponsor

argenx